3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
4
Thoracic
1
Sarcoma
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Prostatic Neoplasms
24
Wilms Tumor
9
Neuroblastoma
7
Lymphoma, Non-Hodgkin
7
Hepatoblastoma
7
Glioma
7
Rhabdoid Tumor
6
Osteosarcoma
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Medulloblastoma
6
Histiocytosis, Langerhans-Cell
6
Ependymoma
6
Sarcoma
5
Rhabdomyosarcoma
5
Central Nervous System Neoplasms
5
Sarcoma, Ewing
4
Lung Neoplasms
4
Carcinoma, Renal Cell
4
Melanoma
3
Endometrial Neoplasms
3
Carcinoma, Transitional Cell
3
Carcinoma, Hepatocellular
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Ovarian Neoplasms
2
Lymphoma
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Interventions
pembrolizumab
50
Nivolumab
21
Docetaxel
11
atezolizumab
7
Ipilimumab
7
avelumab
6
Cyclophosphamide
6
Paclitaxel
5
Cetuximab
5
Carboplatin
5
fludarabine
4
Radiotherapy
4
Gemcitabine
4
utomilumab
3
spartalizumab
3
lenvatinib
3
durvalumab
3
Trastuzumab
3
Specimen Handling
3
Interleukin-2
3
Cisplatin
3
Bevacizumab
3
Albumin-Bound Paclitaxel
3
zimberelimab
2
tremelimumab
2
tisotumab vedotin
2
tislelizumab
2
sargramostim
2
obinutuzumab
2
epacadostat
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Squamous Cell Carcinoma of Head and Neck
×
X-Rays
×
Genitourinary
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled